Aurinia Pharmaceuticals Inc. ( AUPH) - Key Metrics
AUPH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.57 | $1.57 | $0.33 | $0.33 |
| 2025Q3 | $0.54 | $0.23 | $0.32 | $0.32 |
| 2025Q2 | $0.50 | $0.15 | $0.32 | $0.32 |
| 2025Q1 | $0.45 | $0.17 | $0.01 | $0.01 |
AUPH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 2.54 |
| 2025Q3 | ? | 12.01 |
| 2025Q2 | ? | 13.67 |
| 2025Q1 | ? | 11.96 |
AUPH Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.66% | ? |
| 2025Q4 | 2.08% | ? |
| 2025Q3 | 2.93% | ? |
| 2025Q2 | 3.75% | ? |
| 2025Q1 | 0.11% | ? |
AUPH
Price: $16
52 week price:
Earnings Per Share: 2.16 USD
P/E Ratio: 7.07
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 2.2 million
Ebitda: -13.4 millionMarket Capitalization: 2.0 billion